Synthesis and antimicrobial activities of His(2-aryl)Arg and Trp-His(2-aryl) classes of dipeptidomimetics

被引：26

作者：

Mahindra, Amit ^{[1
]}

Sharma, Krishna K. ^{[1
]}

Rathore, Dinesh ^{[1
]}

Khan, Shabana. I. ^{[2
]}

Jacob, Melissa R. ^{[2
]}

Jain, Rahul ^{[1
]}

机构：

[1] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Sas Nagar 160062, Punjab, India

[2] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA

来源：

MEDCHEMCOMM | 2014年 / 5卷 / 05期

关键词：

CRYPTOCOCCAL MENINGITIS; ANTIFUNGAL AGENTS; FUNGAL-INFECTIONS; PEPTIDE-SYNTHESIS; AMPHOTERICIN-B; ECHINOCANDINS; BURDEN; YEASTS; ACIDS;

D O I：

10.1039/c4md00041b

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this communication, we report the design, synthesis and in vitro antimicrobial activity of ultra short peptidomimetics. Besides producing promising antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), the dipeptidomimetics exhibited high antifungal activity against C. neoformans with IC50 values in the range of 0.16-19 mu g mL(-1). The most potent analogs exhibited 4-fold higher activity than the currently used drug amphotericin B, with no apparent cytotoxicity in a panel of mammalian cell lines.

引用

页码：671 / 676

页数：6

共 33 条

[1]

BAILEY EM, 1990, PHARMACOTHERAPY, V10, P146

[2]

BORENFREUND E, 1990, IN VITRO CELL DEV B, V26, P1030

[3] Antifungal Drug Discovery: Something Old and Something New [J].

Butts, Arielle ;

Krysan, Damian J. .

PLOS PATHOGENS, 2012, 8 (09)

[4] The Future of Peptide-based Drugs [J].

Craik, David J. ;

Fairlie, David P. ;

Liras, Spiros ;

Price, David .

CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (01) :136-147

[5] Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi [J].

Cuenca-Estrella, M ;

Gomez-Lopez, A ;

Mellado, E ;

Buitrago, MJ ;

Monzon, A ;

Rodriguez-Tudela, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :917-921

[6] Echinocandins: a new class of antifungal [J].

Denning, DW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :889-891

[7]

Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226

[8] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956

[9] Antimicrobial peptides stage a comeback [J].

Fox, Jeffrey L. .

NATURE BIOTECHNOLOGY, 2013, 31 (05) :379-382

[10] In vitro antibacterial properties of pexiganan, an analog of magainin [J].

Ge, YG ;

MacDonald, DL ;

Holroyd, KJ ;

Thornsberry, C ;

Wexler, H ;

Zasloff, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :782-788

← 1 2 3 4 →